QINWEN MAO portrait
  • Professor (Clinical), Pathology
801-213-4271

Languages

  • English, Fluent.

Publications

  • Lall RR, Shafizadeh SF, Lee KH, Mao Q, Mehta M, Raizer J, Bendok BR, Chandler JP (date unknown). Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy. (pp. 59). Vol. 4. Accepted, .
  • Zhang W, Zheng X, Wang Y, Mao Q, Xia H (date unknown). Establishment of a cell line carrying single copy of an exogenous mutant reporter gene for assaying the biological activity of ZFNs. Vol. 162, 191-6. Accepted, .
  • Chen H, Li Y, Du C, Li Y, Zhao J, Zheng X, Mao Q, Xia H (date unknown). Aptazyme-mediated direct modulation of post-transcriptional sgRNA level for conditional genome editing and gene expression. Vol. 288, 23-29. Accepted, .
  • Mao Q, Xia H, Davidson BL (date unknown). Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease. Vol. 555, 351-7. Accepted, .
  • Li Y, Li S, Li Y, Xia H, Mao Q (date unknown). Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene. Vol. 10, 98-107. Accepted, .
  • Zhu J, Wang N, Li X, Zheng X, Zhao J, Xia H, Mao Q (date unknown). Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration. Vol. 78, 1124-1129. Accepted, .
  • Zhang J, Zhao J, Mao Q, Xia H (date unknown). A simple, efficient and economical method for isolating and culturing human umbilical cord blood‑derived mesenchymal stromal cells. Vol. 20, 5257-5264. Accepted, .
  • Li Z, Zhao J, Muhammad N, Wang D, Mao Q, Xia H (date unknown). Establishment of a HEK293 cell line by CRISPR/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene. Vol. 40, 1495-1506. Accepted, .
  • Li Y, Zhang W, Zhao J, Li S, Shan L, Zhu J, Li Y, Zhu H, Mao Q, Xia H (date unknown). Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system. Vol. 70, 1595-1605. Accepted, .
  • Dai X, Li Y, Sun X, Cai K, Mao Q, Xia H (date unknown). Generation of Domain-Specific Monoclonal Antibodies Against Human Glutaredoxin3. Vol. 35, 285-292. Accepted, .
  • Li Y, Li Y, Zhao J, Zheng X, Mao Q, Xia H (date unknown). Development of a Sensitive Luciferase-Based Sandwich ELISA System for the Detection of Human Extracellular Matrix 1 Protein. Vol. 35, 273-279. Accepted, .
  • Chen H, Zheng X, Di B, Wang D, Zhang Y, Xia H, Mao Q (date unknown). Aptamer modification improves the adenoviral transduction of malignant glioma cells. Vol. 168, 362-6. Accepted, .
  • Li X, Mao Q, Wang D, Xia H (date unknown). A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy. Vol. 41, 2159-65. Accepted, .
  • Xia H, Anderson B, Mao Q, Davidson BL (date unknown). Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. Vol. 74, 11359-66. Accepted, .
  • Zhang W, Xiao D, Shan L, Zhao J, Mao Q, Xia H (date unknown). Generation of apoptosis-resistant HEK293 cells with CRISPR/Cas mediated quadruple gene knockout for improved protein and virus production. Vol. 114, 2539-2549. Accepted, .
  • Mao Q, Wang D, Li Y, Kohler M, Wilson J, Parton Z, Shmaltsuyeva B, Gursel D, Rademakers R, Weintraub S, Mesulam MM, Xia H, Bigio EH (date unknown). Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration. Vol. 76, 957-968. Accepted, .
  • Ampie L, Choy W, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O (date unknown). Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature. Vol. 138, 129-36. Accepted, .
  • Jara JH, Gautam M, Kocak N, Xie EF, Mao Q, Bigio EH, Özdinler PH (date unknown). MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology. Vol. 16, 196. Accepted, .
  • Zhang W, Chen H, Zheng X, Wang D, Ji H, Xia H, Mao Q (date unknown). Targeted genome correction by a single adenoviral vector simultaneously carrying an inducible zinc finger nuclease and a donor template. Vol. 188, 1-6. Accepted, .
  • Sleat DE, Wiseman JA, El-Banna M, Kim KH, Mao Q, Price S, Macauley SL, Sidman RL, Shen MM, Zhao Q, Passini MA, Davidson BL, Stewart GR, Lobel P (date unknown). A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. Vol. 24, 9117-26. Accepted, .
  • Maniar KP, Arva N, Blanco LZ Jr, Mao Q, Morency EG, Rodriguez R, Wolniak K, Yaseen NR, Nayar R (date unknown). Accreditation Council for Graduate Medical Education Self-Study for Pathology: One Institution's Experience and Lessons Learned. Vol. 143, 1271-1277. Accepted, .
  • Muhammad N, Mao Q, Xia H (date unknown). CAR T-cells for cancer therapy. Vol. 33, 190-226. Accepted, .
  • Xia H, Mao Q, Paulson HL, Davidson BL (date unknown). siRNA-mediated gene silencing in vitro and in vivo. Vol. 20, 1006-10. Accepted, .
  • Eliason SL, Stein CS, Mao Q, Tecedor L, Ding SL, Gaines DM, Davidson BL (date unknown). A knock-in reporter model of Batten disease. Vol. 27, 9826-34. Accepted, .
  • Zheng X, Mao Q, Wang D, Zhao J, Xia H (date unknown). A novel system for rapid screening of effective siRNA target sites by one step transfection with a single vector. Vol. 155, 135-9. Accepted, .
  • Mao Q, Zheng X, Gefen T, Rogalski E, Spencer CL, Rademakers R, Fought AJ, Kohler M, Weintraub S, Xia H, Mesulam MM, Bigio EH (date unknown). FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology. Vol. 78, 844-853. Accepted, .
  • Zhang LF, Mao QW, Ma J, Yu ZB (date unknown). Effects of simulated weightlessness on arterial vasculature (an experimental study on vascular deconditioning). Vol. 3, 5-8. Accepted, .
  • Li X, Xia R, Zhao J, Wang D, Mao Q, Xia H (date unknown). A one-step ligation system for rapid generation of armed, conditionally-replicating adenoviruses. Vol. 35, 1215-21. Accepted, .
  • Orii KO, Grubb JH, Vogler C, Levy B, Tan Y, Markova K, Davidson BL, Mao Q, Orii T, Kondo N, Sly WS (date unknown). Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Vol. 12, 345-52. Accepted, .
  • Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, Paulson HL, Yang L, Kotin RM, Davidson BL (date unknown). RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Vol. 10, 816-20. Accepted, .
  • Mao QW, Zhang LF, Zhang LN, Ma J (date unknown). [Ultrastructural changes of arterial wall from different body parts of rats during simulated weightlessness]. Vol. 12, 249-53. Accepted, .
  • Zheng X, Mi T, Wang R, Zhang Z, Li W, Zhao J, Yang P, Xia H, Mao Q (date unknown). Progranulin deficiency promotes persistent neuroinflammation and causes regional pathology in the hippocampus following traumatic brain injury. Vol. 70, 1317-1336. Accepted, .
  • Kam KL, Appin CL, Mao Q, Ikegami S, Lukas RV, Nikiforova MN, Roy S, Brat DJ, Horbinski C (date unknown). Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?. Vol. 79, 763-766. Accepted, .
  • Chen F, Li Y, Zhao J, Mao Q, Xia H (date unknown). Domain-Specific Monoclonal Antibodies Against Human Rev-erbβ. Vol. 182, 978-989. Accepted, .
  • Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ (date unknown). Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG). Vol. 76, 605-619. Accepted, .
  • Lall RR, Lall RR, Smith TR, Lee KH, Mao Q, Kalapurakal JA, Marymont MH, Chandler JP (date unknown). Delayed malignant transformation of petroclival meningioma to chondrosarcoma after stereotactic radiosurgery. Vol. 21, 1225-8. Accepted, .
  • Xia H, Mao Q, Davidson BL (date unknown). The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Vol. 19, 640-4. Accepted, .
  • Mao QW, Zhang LF, Ma J (date unknown). Observations on arteriolar network structure in soleus of tail-suspended rats. Vol. 4, P129-30. Accepted, .
  • McCord MR, Bigio EH, Kam KL, Fischer V, Obeidin F, White CL, Brat DJ, Muller WA, Mao Q (date unknown). Spinocerebellar Ataxia Type 3: A Case Report and Literature Review. Vol. 79, 641-646. Accepted, .
  • Zhang D, Kim SSR, Kelly DF, Asa SL, Movassaghi M, Mareninov S, Yong WH, Cloughesy TF, Rodriguez FJ, McKeever P, Qian J, Li JY, Mao Q, Newell KL, Green RM, Welsh CT, Xiong Z, Heaney AP (date unknown). Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma. Vol. 104, 2395-2402. Accepted, .
  • Ampie L, Choy W, DiDomenico JD, Lamano JB, Williams CK, Kesavabhotla K, Mao Q, Bloch O (date unknown). Clinical attributes and surgical outcomes of angiocentric gliomas. Vol. 28, 117-22. Accepted, .
  • Wang D, Guo Y, Li Y, Li W, Zheng X, Xia H, Mao Q (date unknown). Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody. Vol. 9, 2603-2608. Accepted, .
  • Li X, Mao Q, Wang D, Zhang W, Xia H (date unknown). A fiber chimeric CRAd vector Ad5/11-D24 double-armed with TRAIL and arresten for enhanced glioblastoma therapy. Vol. 23, 589-96. Accepted, .
  • Chai L, Mao Q, Liu S, Xia H (date unknown). Domain-specific monoclonal antibodies produced against human PGRN. Vol. 30, 271-8. Accepted, .
  • Zhang LF, Yu ZB, Ma J, Mao QW (date unknown). Peripheral effector mechanism hypothesis of postflight cardiovascular dysfunction. Vol. 72, 567-75. Accepted, .
  • Mao QW, Zhang LF, Ma J (date unknown). [Changes in lumen diameters of vessels in arteriolar network in rat soleus muscle after simulated weightlessness]. Vol. 12, 177-80. Accepted, .
  • Apple AC, Mao Q, Bigio E, Bonakdarpour B (date unknown). Sleep talking and primary progressive aphasia: case study and autopsy findings in a patient with logopenic primary progressive aphasia and dementia with Lewy bodies. Vol. 12. Accepted, .
  • Rogalski E, Gefen T, Mao Q, Connelly M, Weintraub S, Geula C, Bigio EH, Mesulam MM (date unknown). Cognitive trajectories and spectrum of neuropathology in SuperAgers: The first 10 cases. Vol. 29, 458-467. Accepted, .
  • Li Y, Wang D, Li Y, Zhu J, Zhao J, Deng Y, Rogalski EJ, Bigio EH, Rademaker AW, Xia H, Mao Q (date unknown). A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders. Vol. 78, 406-415. Accepted, .
  • Gefen T, Ahmadian SS, Mao Q, Kim G, Seckin M, Bonakdarpour B, Ramos EM, Coppola G, Rademakers R, Rogalski E, Rademaker A, Weintraub S, Mesulam MM, Geula C, Bigio EH (date unknown). Combined Pathologies in FTLD-TDP Types A and C. Vol. 77, 405-412. Accepted, .
  • Li Y, Li Y, Zhao J, Wang D, Mao Q, Xia H (date unknown). Production and characterization of domain-specific monoclonal antibodies against human ECM1. Vol. 121, 103-11. Accepted, .
  • Gu J, Yang T, Xing X, Kuang Y, Cheng G, Zhang J, Huang Y, Zhang B, Dong L, Mao Q (date unknown). A dorsally located giant posterior fossa neurenteric cyst in a Chinese woman. Vol. 22, 917-8. Accepted, .
  • Wang D, Li W, Zhang H, Mao Q, Xia H (date unknown). A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line. Vol. 31, 2093-8. Accepted, .
  • Mao Q, Foster BJ, Xia H, Davidson BL (date unknown). Membrane topology of CLN3, the protein underlying Batten disease. Vol. 541, 40-6. Accepted, .
  • Kim M, Mao Q, Davidson BL, Wiemer DF (date unknown). Tripeptide probes for tripeptidyl protease I production via gene transfer. Vol. 46, 1603-8. Accepted, .
  • Mesulam MM, Coventry CA, Bigio EH, Sridhar J, Gill N, Fought AJ, Zhang H, Thompson CK, Geula C, Gefen T, Flanagan M, Mao Q, Weintraub S, Rogalski EJ (date unknown). Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia. Accepted, .
  • Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL, Davidson BL (date unknown). RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Vol. 102, 5820-5. Accepted, .
  • Zheng X, Mi T, Wang R, Zhang Z, Li W, Zhao J, Yang P, Xia H, Mao Q (date unknown). Progranulin deficiency promotes persistent neuroinflammation and causes regional pathology in the hippocampus following traumatic brain injury. Accepted, .
  • Shan L, Wang D, Mao Q, Xia H (date unknown). Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene. Vol. 187, 1344-1355. Accepted, .
  • Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM (date unknown). Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Vol. 33, 122-33. Accepted, .
  • Lee KH, Lall RR, Chandler JP, Bigio EH, Mao Q (date unknown). Pineal chordoid meningioma complicated by repetitive hemorrhage during pregnancy: case report and literature review. Vol. 33, 192-8. Accepted, .
  • Chai L, Liu S, Mao Q, Wang D, Li X, Zheng X, Xia H (date unknown). A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy. Vol. 19, 247-54. Accepted, .
  • Liu S, Mao Q, Zhang W, Zheng X, Bian Y, Wang D, Li H, Chai L, Zhao J, Xia H (date unknown). Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Vol. 29, 103-9. Accepted, .
  • Mao QW, Zhang LF, Ma J (date unknown). [Differentiated remodeling changes of medium-sized arteries from different body parts in tail-suspended rats and their reversibility]. Vol. 12, 92-6. Accepted, .
  • Zheng X, Li Y, Zhao J, Wang D, Xia H, Mao Q (date unknown). Production and Characterization of Monoclonal Antibodies against Human Nuclear Protein FAM76B. Vol. 11, e0152237. Accepted, .
  • Wang D, Liu S, Mao Q, Zhao J, Xia H (date unknown). A novel vector for a rapid generation of fiber-mutant adenovirus based on one step ligation and quick screening of positive clones. Vol. 152, 72-6. Accepted, .
  • Stanley NE, Robinson LJ, Mao Q (date unknown). A Novel, Heterozygous BSCL2 Variant in Association With Early-Onset Epileptic Encephalopathy. Accepted, .
  • Zhang W, Wang D, Liu S, Zheng X, Ji H, Xia H, Mao Q (date unknown). Multiple copies of a linear donor fragment released in situ from a vector improve the efficiency of zinc-finger nuclease-mediated genome editing. Vol. 21, 282-8. Accepted, .
  • Muhammad N, Wang R, Li W, Zhang Z, Chang Y, Hu Y, Zhao J, Zheng X, Mao Q, Xia H (date unknown). A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy. Vol. 24, 729-741. Accepted, .
  • Chen H, Wang D, Xia R, Mao Q, Xia H (date unknown). A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression. Vol. 15, 4. Accepted, .
  • Xiao D, Zhang W, Li Y, Liu K, Zhao J, Sun X, Shan L, Mao Q, Xia H (date unknown). A novel luciferase knock-in reporter system for studying transcriptional regulation of the human Sox2 gene. Vol. 219, 110-6. Accepted, .
  • Di B, Mao Q, Zhao J, Li X, Wang D, Xia H (date unknown). A rapid generation of adenovirus vector with a genetic modification in hexon protein. Vol. 157, 373-8. Accepted, .
  • Zhang J, Zhao J, Zheng X, Cai K, Mao Q, Xia H (date unknown). Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGKθ gene knockout. Vol. 17, 2169-2176. Accepted, .
  • Li Y, Li Y, Ye M, Wang D, Zhao J, Sun X, Mao Q, Xia H (date unknown). Biological function analysis of monoclonal antibodies against human granulins in vitro using U251 cells as a model. Vol. 130, 55-62. Accepted, .
  • Passini MA, Dodge JC, Bu J, Yang W, Zhao Q, Sondhi D, Hackett NR, Kaminsky SM, Mao Q, Shihabuddin LS, Cheng SH, Sleat DE, Stewart GR, Davidson BL, Lobel P, Crystal RG (date unknown). Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. Vol. 26, 1334-42. Accepted, .
  • Hojat A, Wei B, Olson MG, Mao Q, Yong WH (date unknown). Procurement and Storage of Surgical Biospecimens. Vol. 1897, 65-76. Accepted, .
  • Huang QQ, Birkett R, Doyle R, Shi B, Roberts EL, Mao Q, Pope RM (date unknown). The Role of Macrophages in the Response to TNF Inhibition in Experimental Arthritis. Vol. 200, 130-138. Accepted, .
  • Hakar M, Chandler JP, Bigio EH, Mao Q (date unknown). Neuroendocrine carcinoma of the pineal parenchyma. The first reported case. Vol. 35, 68-70. Accepted, .
  • Choy W, Ampie L, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O (date unknown). Predictors of recurrence in the management of chordoid meningioma. Vol. 126, 107-116. Accepted, .
  • Choy W, Ampie L, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O (date unknown). Erratum to: Predictors of recurrence in the management of chordoid meningioma. Vol. 126, 117. Accepted, .
  • Zhang W, Guo Y, Zhang C, Ji H, Meng W, Wang D, Li X, Mao Q, Xia H (date unknown). Rescue the failed half-ZFN by a sensitive mammalian cell-based luciferase reporter system. Vol. 7, e45169. Accepted, .
  • Zhang LF, Yu ZB, Ma J, Mao QW (date unknown). [Peripheral effector mechanism hypothesis on cardiovascular dysfunction after spaceflight]. Vol. 32, 13-7. Accepted, .
  • Bit-Ivan EN, Lee KH, Gitelman D, Weintraub S, Mesulam M, Rademakers R, Isaacs AM, Hatanpaa KJ, White CL 3rd, Mao Q, Akman O, DiMauro S, Bigio EH (date unknown). Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration. (pp. 778-82). Vol. 40. Accepted, .
  • Nishihira Y, Gefen T, Mao Q, Appin C, Kohler M, Walker J, Rademakers R, Rademaker A, Rogalski E, Weintraub S, Geula C, Mesulam MM, Bigio EH (date unknown). Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes. (pp. 167-169). Vol. 138. Accepted, .
  • Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R, Peterson M, Siddique N, Geula C, Siddique T, Mesulam M (date unknown). Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. (pp. 463-5). Vol. 125. Accepted, .
  • Zhang J, Chen H, Chen C, Liu H, He Y, Zhao J, Yang P, Mao Q, Xia H (date unknown). Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy. (pp. 26-38). Vol. 509. Accepted, .